Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3100 Triple Negative Breast Neoplasms 505 Ovarian Neoplasms 225 Colorectal Neoplasms 190 Carcinoma, Non-Small-Cell Lung 187 Prostatic Neoplasms 181 Neoplasms 171 Lung Neoplasms 166 Neoplasm Metastasis 161 Melanoma 117 Stomach Neoplasms 113 Pancreatic Neoplasms 112 Endometrial Neoplasms 105 Uterine Cervical Neoplasms 93 Squamous Cell Carcinoma of Head and Neck 87 Head and Neck Neoplasms 82 Colonic Neoplasms 81 Carcinoma, Intraductal, Noninfiltrating 80 Sarcoma 63 Breast Carcinoma In Situ 61 Urinary Bladder Neoplasms 60 Carcinoma, Renal Cell 60 Esophageal Neoplasms 58 Motor Activity 57 Brain Neoplasms 50 Lymphedema 42 Advanced Breast Cancer 41 Liver Neoplasms 39 HER2-positive Breast Cancer 38 Gastrointestinal Neoplasms 38

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Breast × 1 year × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡